Loading...

DAPI (4',6-Diamidino-2-Phenylindole, Dilactate) DAPI (4',6-Diamidino-2-Phenylindole, Dilactate)

Pricing & Availability
Regulatory Status
RUO
Other Names
4',6-Diamidino-2-Phenylindole, Dilactate
Ave. Rating
Submit a Review
Product Citations
publications
1_Ankita_Patil.jpg
Methanol fixed superior cervical ganglion neurons were stained with anti-tubulin β3 (pink) and anti-TRIM46 (aqua), then stained with secondary antibodies, phalloidin (orange) and DAPI (blue). Image generously submitted to the 2017 Cell Life Imaging Competition by Ankita Patil from Drexel University.
  • 1_Ankita_Patil.jpg
    Methanol fixed superior cervical ganglion neurons were stained with anti-tubulin β3 (pink) and anti-TRIM46 (aqua), then stained with secondary antibodies, phalloidin (orange) and DAPI (blue). Image generously submitted to the 2017 Cell Life Imaging Competition by Ankita Patil from Drexel University.
  • 2_Kathleen-Ignatoski
    Frozen mouse intestine stained with purified anti-Ankyrin-B (green), E-Cadherin (red) and DAPI (blue) followed by anti-goat Alexa Fluor® 488 and anti-rabbit Alexa Fluor® 568. Image generously submitted to the 2017 Cell Life Imaging Competition by Kathleen Ignatoski from University of Michigan.
  • 3_KifLiakath.jpg
    Whole mount mouse tail epidermis was stained with purified anti-Keratin 14 (green, clone Poly19053), purified anti-Keratin 15 (orange, clone Poly18339) and DAPI (blue). Image generously submitted to the 2017 Cell Life Imaging Competition by Kif Liakath.
  • 4_DAPI_IF_080712
    Human cervical cancer cell line, HeLa, was fixed with 4% paraformaldehyde and stained with 300 nM DAPI.
  • 5_DAPI_080712
    Human cervical cancer cell line, HeLa, was fixed with 4% paraformaldehyde and stained with 300 nM DAPI.
See DAPI (4',6-Diamidino-2-Phenylindole, Dilactate) spectral data
Cat # Size Price Quantity Check Availability Save
422801 10 mg SEK849
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

DAPI (4',6-Diamidino-2-Phenylindole, Dilactate), a blue fluorescent nucleic acid stain, preferentially binds dsDNA and associates with the minor groove AT clusters. The molecular weight for DAPI is 457.5.  Association of DAPI with dsDNA increases fluorescence approximately 20-fold, with an emission maximum of 460 nm. The increase in fluorescence is believed to be due to displacement of water molecules from the minor groove and DAPI. DAPI can also bind RNA and emits at a longer wavelength of 500 nm, with only a 20% increase in fluorescence.

DAPI is a popular nuclear stain for identification of cell cycle and specifically stains nuclei but not cytoplasm. The dilactate form is more water soluble compared to the dihydrochloride form.

DAPI can be excited by a UV laser, xenon, or a mercury-arc lamp. 

Product Details
Technical Data Sheet (pdf)

Product Details

Formulation
Lyophilized
Preparation
To make 5 mg/ml (10.9 mM) solution, dissolve entire contents of vial in 2 ml of deionized water.
Storage & Handling
Store between 2°C and 8°C, protected from light. For long term storage, aliquot and store at -20°C.
Application

ICFC, ICC
Recommended Usage

This product can be used at 30 µM for flow cytometry and 300 nM for immunofluorescence.  It is recommended to titrate the dye for optimal performance. 

Excitation Laser
Ultraviolet Laser (355 nm)
Application Notes

Protocols for Counterstaining with DAPI:

Immunofluorescence Staining
Note: Cells may be fixed by method of choice, such as with 4% paraformaldehyde. DAPI staining is done after staining for other markers. Fixation and permeabilization of cells is not necessary to counterstain with DAPI.

1. Fix cells using method of choice.
2. Incubate the cells with phosphate buffered saline (PBS) for 15 minutes.
3. Dilute the DAPI solution (we recommend to 300 nM) with PBS. Remove excess PBS from the slide and cover with DAPI solution, making sure the cells are completely covered.
4. Incubate for up to 5 minutes. Rinse the slide several times to remove all free DAPI. It is recommended to use a mounting medium with antifade reagent to reduce fluorescence quenching. The slide is ready to view under the microscope with appropriate filters.


Nuclear Staining for Flow Cytometry
Note: Cells may be fixed with 4% paraformadehyde or absolute ethanol.

1. Fix cells with absolute ethanol or 4% paraformaldehyde.
2. Centrifuge, discard the supernatant, and add 5 ml of PBS, allowing cells to rehydrate for 15 minutes.
3. Dilute the DAPI to 30 µM (recommended) in staining buffer (such as BioLegend's FOXP3 Perm Buffer, Cat. No. 421402).
4. Centrifuge cell suspension from step 3 above, discard supernatant, and add 1 ml of DAPI solution; then incubate at room temperature for 15 minutes.
5. Analyze by flow cytometry using an instrument with appropriate lasers.

Additional Product Notes

View more applications data for this product in our Scientific Poster Library.

Application References
  1. Solomonov I, et al. 2014. Sci Rep. 4:5987. PubMed
  2. Sodhi CP, et al. 2015. J Immunol. 194:4931. PubMed
Product Citations
  1. Sierro F, et al. 2017. Immunity. 47:374. PubMed
  2. Wiedemann SJ, et al. 2022. Cell Metab. 34:991. PubMed
  3. Michalek S, et al. 2022. EMBO Rep. 23:e54195. PubMed
  4. Cherkaoui S, et al. 2022. Mol Syst Biol. 18:e11033. PubMed
  5. Chang L, et al. 2023. Life Sci Alliance. 6:. PubMed
  6. Kozlovski S, et al. 2023. Front Immunol. 13:1041552. PubMed
  7. Vanneste D, et al. 2023. Nat Immunol. 24:827. PubMed
  8. Flinn MA, et al. 2023. Front Cardiovasc Med. 10:1142612. PubMed
  9. Ramalingam P, et al. 2023. Nat Commun. 14:2018. PubMed
  10. Huber M, et al. 2023. Nat Commun. 14:2143. PubMed
  11. Kerkering J, et al. 2023. J Clin Invest. . PubMed
  12. Basta MD, et al. 2023. iScience. 26:106570. PubMed
  13. Arora S, et al. 2023. PLoS One. 18:e0286211. PubMed
  14. Gómez-Pinedo U, et al. 2023. Cells. 12:. PubMed
  15. Hoover MY, et al. 2023. Nat Protoc. . PubMed
  16. Davila ML, et al. 2022. iScience. 25:104426. PubMed
  17. DeDreu J, et al. 2021. Matrix Biol. 96:18. PubMed
  18. Duraiswamy J, et al. 2021. Cancer Cell. 39:1623. PubMed
  19. McCubbrey AL, et al. 2022. Cell Rep. 38:110222. PubMed
  20. Xiang J, et al. 2022. J Virol. 96:e0005722. PubMed
  21. Matta B, et al. 2022. Front Immunol. 13:951254. PubMed
  22. Kimmerling RJ, et al. 2022. Commun Biol. 5:1295. PubMed
  23. Reemst K, et al. 2022. Transl Psychiatry. 12:507. PubMed
  24. Kaneko K, et al. 2022. Cancers (Basel). 14: . PubMed
  25. Shahid AM, et al. 2022. PLoS One. 17:e0278209. PubMed
  26. Sountoulidis A, et al. 2023. Nat Cell Biol. 25:351. PubMed
  27. Wang CQ, et al. 2023. Cells. 12: . PubMed
  28. Jeon EY, et al. 2023. Bioeng Transl Med. 8:e10362. PubMed
  29. Xiong E, et al. 2023. Front Immunol. 13:1083119. PubMed
  30. Aru B, et al. 2023. Balkan Med J. 40:117. PubMed
  31. González-Terán B, et al. 2022. Cell. 185:794. PubMed
  32. Grubwieser P, et al. 2022. Front Cell Infect Microbiol. 12:875543. PubMed
  33. Wu N, et al. 2020. Cell Rep. 30:1129. PubMed
  34. Velilla J, et al. 2019. Neurol Genet. 5:e312. PubMed
  35. Jiao Q, et al. 2017. Clin Exp Immunol. 188:420. PubMed
  36. Rodrigues M, et al. 2022. Biochem J. 479:1891. PubMed
  37. Gabriely G, et al. 2021. iScience. 24:103347. PubMed
  38. Effern M, et al. 2022. STAR Protoc. 3:101038. PubMed
  39. Sountoulidis A, et al. 2020. PLoS Biol. 18:e3000675. PubMed
  40. Mester B, et al. 2015. PLoS One. 10: e0140432. PubMed
  41. Kobayashi T, et al. 2019. Cell. 176:982. PubMed
  42. Anguiano T, et al. 2020. Toxicol Sci. 177:494. PubMed
  43. Afshar Y, et al. 2021. Nat Commun. 12:4408. PubMed
  44. Goodnough LH, et al. 2022. Front Endocrinol (Lausanne). 13:924927. PubMed
  45. Nguyen DT, et al. 2022. Cells. 11:. PubMed
  46. Baldominos P, et al. 2022. STAR Protoc. 3:101795. PubMed
  47. Wilson K, et al. 2016. Cell Death Dis. 7: e2197. PubMed
  48. Miedema A, et al. 2022. Acta Neuropathol Commun. 10:8. PubMed
  49. Emmons TR, et al. 2021. Cancer Immunol Res. 9:790. PubMed
  50. Valkov N, et al. 2021. Life Sci Alliance. 4:. PubMed
  51. Gamboa CM, et al. 2021. STAR Protoc. 100345:2. PubMed
  52. Sugawara E, et al. 2020. Autophagy. 1.323611111. PubMed
  53. Elias A, et al. 2016. Sci Rep. 6: 24971. PubMed
  54. Brunner JS, et al. 2020. Nat Commun. 0.757638889. PubMed
  55. Fukushima T, et al. 2019. Cell Rep. 29:4144. PubMed
  56. Bannard O, et al. 2016. J Exp Med. 13: 993 - 1009. PubMed
  57. Sumitomo Y, et al. 2016. Blood. 128: 1614 - 1624. PubMed
  58. Paris AJ, et al. 2020. Nat Cell Biol. 1.747916667. PubMed
  59. Zhang M, et al. 2017. Oncol Lett. 3.069444444. PubMed
  60. Greenblatt SM, et al. 2018. Cancer Cell. 33:1111. PubMed
  61. Alexander MS, et al. 2021. Muscle Nerve. 63:928. PubMed
  62. Hendricks A, et al. 2021. Front Oncol. 11:646885. PubMed
  63. Hiramatsu-Asano S, et al. 2021. Front Immunol. 11:616141. PubMed
  64. Ambrosi TH, et al. 2021. Elife. 10: . PubMed
  65. Hopp AK, et al. 2021. Mol Cell. 81:340. PubMed
  66. Allam O, et al. 2018. PLoS One. 13:e0194185. PubMed
  67. Wilson AS, et al. 2022. Nat Commun. 13:528. PubMed
  68. Deng J, et al. 2021. Breast Cancer Res Treat. 185:85. PubMed
  69. DeDreu J, et al. 2020. FASEB J. 34:9316. PubMed
  70. Kanda K, et al. 2018. JCI Insight. 3:e91316. PubMed
  71. Fujiwara H, et al. 2021. Nat Immunol. 22:1440. PubMed
  72. Ravi A, et al. 2021. Dev Cell. 56:1661. PubMed
  73. Wu CL, et al. 2021. Nat Commun. 12:362. PubMed
  74. Koh P, et al. 2016. Sci Data. 3:160109. PubMed
  75. Sodhi C, et al. 2015. J Immunol. 194:4931. PubMed
  76. Wang ECE, et al. 2019. Cell Stem Cell. 24:654. PubMed
  77. So EY, et al. 2021. Am J Physiol Cell Physiol. 321:C569. PubMed
  78. Poulos M, et al. 2016. Nat Commun. 7:13829. PubMed
  79. Noah AC, et al. 2020. J Appl Physiol (1985). 473:128. PubMed
  80. Teo YV, et al. 2019. Cell Rep. 27:997. PubMed
  81. Hayama Y, et al. 2018. J Immunol. 200:3790. PubMed
  82. Fredriksson-Lidman K, et al. 2017. PLoS One. 10.1371/journal.pone.0185509. PubMed
  83. Wennerberg E, et al. 2022. Sci Transl Med. 14:eabe8195. PubMed
  84. Kumar A, et al. 2021. STAR Protoc. 2:100874. PubMed
  85. Hendricks A, et al. 2020. Cancers (Basel). 12:00. PubMed
  86. Aronovich A, et al. 2021. J Invest Dermatol. 141:619. PubMed
  87. Caeser R, et al. 2021. Nat Protoc. 16:2499. PubMed
  88. Faisal S, et al. 2016. Sci Rep. 6:39530. PubMed
  89. Kundu K, et al. 2019. Cancer Immunol Res. 1.069444444. PubMed
  90. Pagan JD, et al. 2018. Cell. 172:564. PubMed
  91. Zhang X, et al. 2022. JCI Insight. 7:. PubMed
  92. Zhu M, et al. 2021. Eneuro. 8:. PubMed
  93. Flores-Pliego A, et al. 2021. Cells. 10:. PubMed
  94. Shani O, et al. 2021. Elife. 10: . PubMed
  95. Thompson M, et al. 2015. J Immunol. 195: 5637 - 5647. PubMed
  96. Mould KJ, et al. 2019. JCI Insight. 4:00. PubMed
  97. Heath O, et al. 2021. Cancer Immunol Res. 9:665. PubMed
  98. Dasinger JH, et al. 2021. Pregnancy Hypertens. 24:126. PubMed
  99. Ren X, et al. 2022. STAR Protoc. 3:101818. PubMed
  100. Moser J, et al. 2016. Sci Rep. 6:35387. PubMed
  101. Yanting C, et al. 2018. J Dairy Sci. 101:1601. PubMed
  102. Kurena B, et al. 2017. Front Immunol. 1.490972222. PubMed
  103. Pinho–Ribeiro FA, et al. 2018. Cell. 173:1083. PubMed
  104. Aziz M, et al. 2017. J Immunol. 10.4049/jimmunol.1602056. PubMed
  105. Pascual-Pasto G, et al. 2022. J Immunother Cancer. 10:. PubMed
  106. Lehrke MJ, et al. 2021. Elife. 10:. PubMed
  107. Wang Y, et al. 2021. EMBO Mol Med. 13:e14089. PubMed
  108. Correa A, et al. 2015. PLoS One. 10: 0143391. PubMed
  109. Chiang M, et al. 2019. Cell Rep. 28:3212. PubMed
  110. Valdespino-Vázquez MY, et al. 2021. J Med Virol. 93:4480. PubMed
  111. Kissiov DU, et al. 2022. Elife. 11:. PubMed
  112. Isobe T, et al. 2022. Nat Commun. 13:4501. PubMed
  113. Dent JR, et al. 2019. J Appl Physiol (1985). 127:1117. PubMed
  114. Schmidt A, et al. 2017. Toxicol Lett. 10.1016/j.toxlet.2017.08.008. PubMed
  115. Canals Hernaez D, et al. 2022. Front Oncol. 12:856424. PubMed
  116. Mascharak S, et al. 2022. Cell Stem Cell. 29:315. PubMed
  117. Rodriguez A, et al. 2021. Cell Stem Cell. 28:33. PubMed
  118. Pang J, et al. 2021. STAR Protoc. 2:100879. PubMed
  119. Haschak M, et al. 2021. Aging (Albany NY). 13:16938. PubMed
  120. Phan TS, et al. 2021. Sci Adv. 7:. PubMed
  121. Stancil IT, et al. 2021. Nat Commun. 12:4566. PubMed
  122. Margaroli C, et al. 2021. Cell Rep Med. :100242. PubMed
  123. Caporarello N, et al. 2020. Aging Cell. 19:e13196. PubMed
  124. Vergoni B, et al. 2016. Diabetes. 65: 3062 - 3074. PubMed
  125. Burns F, et al. 2015. Aquatic Toxicology. 164: 52-60. PubMed
  126. Stevens M, et al. 2016. Nat Biotechnol. 34:1161-1167. PubMed
  127. Shilts J, et al. 2021. Sci Rep. 0.745138889. PubMed
  128. Jain A, et al. 2020. Nat Immunol. 0.920138889. PubMed
  129. Zheng C, et al. 2022. Acta Pharm Sin B. 12:3726. PubMed
  130. Anisul M, et al. 2021. Elife. 10:. PubMed
  131. DeDreu J, et al. 2022. FASEB J. 36:e21995. PubMed
  132. Pelham-Webb B, et al. 2021. Mol Cell. 81:1732. PubMed
  133. Kohn M, et al. 2021. Front Immunol. 626627:12. PubMed
  134. Chmielewski M and Abken H 2017. Cell Rep.. 10.1016/j.celrep.2017.11.063. PubMed
  135. Hassanein W, et al. 2017. Organogenesis. 13:16. PubMed
  136. Aimi F, et al. 2021. Mod Pathol. 34:1468. PubMed
  137. Barcia Durán JG, et al. 2021. Commun Biol. 4:406. PubMed
  138. Karimzadeh A, et al. 2021. Front Cell Dev Biol. 9:734176. PubMed
  139. Reeves KM, et al. 2021. Clin Cancer Res. Online ahead of print. PubMed
  140. Srijiwangsa P, et al. 2018. BMC Pharmacol Toxicol. 19:32. PubMed
  141. Ladd MR, et al. 2018. Tissue Eng Part C Methods. 24:331. PubMed
  142. Bennett AH, et al. 2018. PLoS Genet. 14:e1007226. PubMed
  143. Doorley L, et al. 2017. Immunobiology.. 10.1016/j.imbio.2017.08.002. PubMed
  144. Guo P, et al. 2022. Nat Cell Biol. 24:99. PubMed
  145. Tominaga K, et al. 2022. iScience. 25:103667. PubMed
  146. Chen HY, et al. 2020. J Immunol. 1158:204. PubMed
  147. Gosztyla C, et al. 2020. Tissue Eng Part C Methods. 26:67. PubMed
  148. Köhler VK, et al. 2020. Int J Mol Sci. 21:00. PubMed
  149. Solomonov I, et al. 2014. Sci Rep. 4:5987. PubMed
  150. Sierro F, et al. 2017. Immunity. 47:374. PubMed
  151. Wiedemann SJ, et al. 2022. Cell Metab. 34:991. PubMed
  152. Michalek S, et al. 2022. EMBO Rep. 23:e54195. PubMed
  153. Cherkaoui S, et al. 2022. Mol Syst Biol. 18:e11033. PubMed
  154. Chang L, et al. 2023. Life Sci Alliance. 6:. PubMed
  155. Kozlovski S, et al. 2023. Front Immunol. 13:1041552. PubMed
  156. Vanneste D, et al. 2023. Nat Immunol. 24:827. PubMed
  157. Flinn MA, et al. 2023. Front Cardiovasc Med. 10:1142612. PubMed
  158. Ramalingam P, et al. 2023. Nat Commun. 14:2018. PubMed
  159. Huber M, et al. 2023. Nat Commun. 14:2143. PubMed
  160. Kerkering J, et al. 2023. J Clin Invest. . PubMed
  161. Basta MD, et al. 2023. iScience. 26:106570. PubMed
  162. Arora S, et al. 2023. PLoS One. 18:e0286211. PubMed
  163. Gómez-Pinedo U, et al. 2023. Cells. 12:. PubMed
  164. Hoover MY, et al. 2023. Nat Protoc. . PubMed
  165. Davila ML, et al. 2022. iScience. 25:104426. PubMed
  166. DeDreu J, et al. 2021. Matrix Biol. 96:18. PubMed
  167. Duraiswamy J, et al. 2021. Cancer Cell. 39:1623. PubMed
  168. McCubbrey AL, et al. 2022. Cell Rep. 38:110222. PubMed
  169. Xiang J, et al. 2022. J Virol. 96:e0005722. PubMed
  170. Matta B, et al. 2022. Front Immunol. 13:951254. PubMed
  171. Kimmerling RJ, et al. 2022. Commun Biol. 5:1295. PubMed
  172. Reemst K, et al. 2022. Transl Psychiatry. 12:507. PubMed
  173. Kaneko K, et al. 2022. Cancers (Basel). 14: . PubMed
  174. Shahid AM, et al. 2022. PLoS One. 17:e0278209. PubMed
  175. Sountoulidis A, et al. 2023. Nat Cell Biol. 25:351. PubMed
  176. Wang CQ, et al. 2023. Cells. 12: . PubMed
  177. Jeon EY, et al. 2023. Bioeng Transl Med. 8:e10362. PubMed
  178. Xiong E, et al. 2023. Front Immunol. 13:1083119. PubMed
  179. Aru B, et al. 2023. Balkan Med J. 40:117. PubMed
  180. González-Terán B, et al. 2022. Cell. 185:794. PubMed
  181. Grubwieser P, et al. 2022. Front Cell Infect Microbiol. 12:875543. PubMed
  182. Wu N, et al. 2020. Cell Rep. 30:1129. PubMed
  183. Velilla J, et al. 2019. Neurol Genet. 5:e312. PubMed
  184. Jiao Q, et al. 2017. Clin Exp Immunol. 188:420. PubMed
  185. Rodrigues M, et al. 2022. Biochem J. 479:1891. PubMed
  186. Gabriely G, et al. 2021. iScience. 24:103347. PubMed
  187. Effern M, et al. 2022. STAR Protoc. 3:101038. PubMed
  188. Sountoulidis A, et al. 2020. PLoS Biol. 18:e3000675. PubMed
  189. Mester B, et al. 2015. PLoS One. 10: e0140432. PubMed
  190. Kobayashi T, et al. 2019. Cell. 176:982. PubMed
  191. Anguiano T, et al. 2020. Toxicol Sci. 177:494. PubMed
  192. Afshar Y, et al. 2021. Nat Commun. 12:4408. PubMed
  193. Goodnough LH, et al. 2022. Front Endocrinol (Lausanne). 13:924927. PubMed
  194. Nguyen DT, et al. 2022. Cells. 11:. PubMed
  195. Baldominos P, et al. 2022. STAR Protoc. 3:101795. PubMed
  196. Wilson K, et al. 2016. Cell Death Dis. 7: e2197. PubMed
  197. Miedema A, et al. 2022. Acta Neuropathol Commun. 10:8. PubMed
  198. Emmons TR, et al. 2021. Cancer Immunol Res. 9:790. PubMed
  199. Valkov N, et al. 2021. Life Sci Alliance. 4:. PubMed
  200. Gamboa CM, et al. 2021. STAR Protoc. 100345:2. PubMed
  201. Sugawara E, et al. 2020. Autophagy. 1.323611111. PubMed
  202. Elias A, et al. 2016. Sci Rep. 6: 24971. PubMed
  203. Brunner JS, et al. 2020. Nat Commun. 0.757638889. PubMed
  204. Fukushima T, et al. 2019. Cell Rep. 29:4144. PubMed
  205. Bannard O, et al. 2016. J Exp Med. 13: 993 - 1009. PubMed
  206. Sumitomo Y, et al. 2016. Blood. 128: 1614 - 1624. PubMed
  207. Paris AJ, et al. 2020. Nat Cell Biol. 1.747916667. PubMed
  208. Zhang M, et al. 2017. Oncol Lett. 3.069444444. PubMed
  209. Greenblatt SM, et al. 2018. Cancer Cell. 33:1111. PubMed
  210. Alexander MS, et al. 2021. Muscle Nerve. 63:928. PubMed
  211. Hendricks A, et al. 2021. Front Oncol. 11:646885. PubMed
  212. Hiramatsu-Asano S, et al. 2021. Front Immunol. 11:616141. PubMed
  213. Ambrosi TH, et al. 2021. Elife. 10: . PubMed
  214. Hopp AK, et al. 2021. Mol Cell. 81:340. PubMed
  215. Allam O, et al. 2018. PLoS One. 13:e0194185. PubMed
  216. Wilson AS, et al. 2022. Nat Commun. 13:528. PubMed
  217. Deng J, et al. 2021. Breast Cancer Res Treat. 185:85. PubMed
  218. DeDreu J, et al. 2020. FASEB J. 34:9316. PubMed
  219. Kanda K, et al. 2018. JCI Insight. 3:e91316. PubMed
  220. Fujiwara H, et al. 2021. Nat Immunol. 22:1440. PubMed
  221. Ravi A, et al. 2021. Dev Cell. 56:1661. PubMed
  222. Wu CL, et al. 2021. Nat Commun. 12:362. PubMed
  223. Koh P, et al. 2016. Sci Data. 3:160109. PubMed
  224. Sodhi C, et al. 2015. J Immunol. 194:4931. PubMed
  225. Wang ECE, et al. 2019. Cell Stem Cell. 24:654. PubMed
  226. So EY, et al. 2021. Am J Physiol Cell Physiol. 321:C569. PubMed
  227. Poulos M, et al. 2016. Nat Commun. 7:13829. PubMed
  228. Noah AC, et al. 2020. J Appl Physiol (1985). 473:128. PubMed
  229. Teo YV, et al. 2019. Cell Rep. 27:997. PubMed
  230. Hayama Y, et al. 2018. J Immunol. 200:3790. PubMed
  231. Fredriksson-Lidman K, et al. 2017. PLoS One. 10.1371/journal.pone.0185509. PubMed
  232. Wennerberg E, et al. 2022. Sci Transl Med. 14:eabe8195. PubMed
  233. Kumar A, et al. 2021. STAR Protoc. 2:100874. PubMed
  234. Hendricks A, et al. 2020. Cancers (Basel). 12:00. PubMed
  235. Aronovich A, et al. 2021. J Invest Dermatol. 141:619. PubMed
  236. Caeser R, et al. 2021. Nat Protoc. 16:2499. PubMed
  237. Faisal S, et al. 2016. Sci Rep. 6:39530. PubMed
  238. Kundu K, et al. 2019. Cancer Immunol Res. 1.069444444. PubMed
  239. Pagan JD, et al. 2018. Cell. 172:564. PubMed
  240. Zhang X, et al. 2022. JCI Insight. 7:. PubMed
  241. Zhu M, et al. 2021. Eneuro. 8:. PubMed
  242. Flores-Pliego A, et al. 2021. Cells. 10:. PubMed
  243. Shani O, et al. 2021. Elife. 10: . PubMed
  244. Thompson M, et al. 2015. J Immunol. 195: 5637 - 5647. PubMed
  245. Mould KJ, et al. 2019. JCI Insight. 4:00. PubMed
  246. Heath O, et al. 2021. Cancer Immunol Res. 9:665. PubMed
  247. Dasinger JH, et al. 2021. Pregnancy Hypertens. 24:126. PubMed
  248. Ren X, et al. 2022. STAR Protoc. 3:101818. PubMed
  249. Moser J, et al. 2016. Sci Rep. 6:35387. PubMed
  250. Yanting C, et al. 2018. J Dairy Sci. 101:1601. PubMed
  251. Kurena B, et al. 2017. Front Immunol. 1.490972222. PubMed
  252. Pinho–Ribeiro FA, et al. 2018. Cell. 173:1083. PubMed
  253. Aziz M, et al. 2017. J Immunol. 10.4049/jimmunol.1602056. PubMed
  254. Pascual-Pasto G, et al. 2022. J Immunother Cancer. 10:. PubMed
  255. Lehrke MJ, et al. 2021. Elife. 10:. PubMed
  256. Wang Y, et al. 2021. EMBO Mol Med. 13:e14089. PubMed
  257. Correa A, et al. 2015. PLoS One. 10: 0143391. PubMed
  258. Chiang M, et al. 2019. Cell Rep. 28:3212. PubMed
  259. Valdespino-Vázquez MY, et al. 2021. J Med Virol. 93:4480. PubMed
  260. Kissiov DU, et al. 2022. Elife. 11:. PubMed
  261. Isobe T, et al. 2022. Nat Commun. 13:4501. PubMed
  262. Dent JR, et al. 2019. J Appl Physiol (1985). 127:1117. PubMed
  263. Schmidt A, et al. 2017. Toxicol Lett. 10.1016/j.toxlet.2017.08.008. PubMed
  264. Canals Hernaez D, et al. 2022. Front Oncol. 12:856424. PubMed
  265. Mascharak S, et al. 2022. Cell Stem Cell. 29:315. PubMed
  266. Rodriguez A, et al. 2021. Cell Stem Cell. 28:33. PubMed
  267. Pang J, et al. 2021. STAR Protoc. 2:100879. PubMed
  268. Haschak M, et al. 2021. Aging (Albany NY). 13:16938. PubMed
  269. Phan TS, et al. 2021. Sci Adv. 7:. PubMed
  270. Stancil IT, et al. 2021. Nat Commun. 12:4566. PubMed
  271. Margaroli C, et al. 2021. Cell Rep Med. :100242. PubMed
  272. Caporarello N, et al. 2020. Aging Cell. 19:e13196. PubMed
  273. Vergoni B, et al. 2016. Diabetes. 65: 3062 - 3074. PubMed
  274. Burns F, et al. 2015. Aquatic Toxicology. 164: 52-60. PubMed
  275. Stevens M, et al. 2016. Nat Biotechnol. 34:1161-1167. PubMed
  276. Shilts J, et al. 2021. Sci Rep. 0.745138889. PubMed
  277. Jain A, et al. 2020. Nat Immunol. 0.920138889. PubMed
  278. Zheng C, et al. 2022. Acta Pharm Sin B. 12:3726. PubMed
  279. Anisul M, et al. 2021. Elife. 10:. PubMed
  280. DeDreu J, et al. 2022. FASEB J. 36:e21995. PubMed
  281. Pelham-Webb B, et al. 2021. Mol Cell. 81:1732. PubMed
  282. Kohn M, et al. 2021. Front Immunol. 626627:12. PubMed
  283. Chmielewski M and Abken H 2017. Cell Rep.. 10.1016/j.celrep.2017.11.063. PubMed
  284. Hassanein W, et al. 2017. Organogenesis. 13:16. PubMed
  285. Aimi F, et al. 2021. Mod Pathol. 34:1468. PubMed
  286. Barcia Durán JG, et al. 2021. Commun Biol. 4:406. PubMed
  287. Karimzadeh A, et al. 2021. Front Cell Dev Biol. 9:734176. PubMed
  288. Reeves KM, et al. 2021. Clin Cancer Res. Online ahead of print. PubMed
  289. Srijiwangsa P, et al. 2018. BMC Pharmacol Toxicol. 19:32. PubMed
  290. Ladd MR, et al. 2018. Tissue Eng Part C Methods. 24:331. PubMed
  291. Bennett AH, et al. 2018. PLoS Genet. 14:e1007226. PubMed
  292. Doorley L, et al. 2017. Immunobiology.. 10.1016/j.imbio.2017.08.002. PubMed
  293. Guo P, et al. 2022. Nat Cell Biol. 24:99. PubMed
  294. Tominaga K, et al. 2022. iScience. 25:103667. PubMed
  295. Chen HY, et al. 2020. J Immunol. 1158:204. PubMed
  296. Gosztyla C, et al. 2020. Tissue Eng Part C Methods. 26:67. PubMed
  297. Köhler VK, et al. 2020. Int J Mol Sci. 21:00. PubMed
  298. Solomonov I, et al. 2014. Sci Rep. 4:5987. PubMed

Antigen Details

Biology Area
Cell Biology, Cell Cycle/DNA Replication, Neuroscience
Antigen References

1. Langlois RG, et al. 1980. Chromosoma. 77:229.
2. Kubista M, et al. 1987. Biochemistry 26:4545.

Gene ID
NA

Related FAQs

There are no FAQs for this product.
Go To Top Version: 2    Revision Date: 04-24-2025

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

Pricing & Availability
Regulatory Status
RUO
Other Names
4',6-Diamidino-2-Phenylindole, Dilactate
Ave. Rating
Submit a Review
Product Citations
publications
1_Ankita_Patil.jpg
Methanol fixed superior cervical ganglion neurons were stained with anti-tubulin β3 (pink) and anti-TRIM46 (aqua), then stained with secondary antibodies, phalloidin (orange) and DAPI (blue). Image generously submitted to the 2017 Cell Life Imaging Competition by Ankita Patil from Drexel University.
  • 1_Ankita_Patil.jpg
    Methanol fixed superior cervical ganglion neurons were stained with anti-tubulin β3 (pink) and anti-TRIM46 (aqua), then stained with secondary antibodies, phalloidin (orange) and DAPI (blue). Image generously submitted to the 2017 Cell Life Imaging Competition by Ankita Patil from Drexel University.
  • 2_Kathleen-Ignatoski
    Frozen mouse intestine stained with purified anti-Ankyrin-B (green), E-Cadherin (red) and DAPI (blue) followed by anti-goat Alexa Fluor® 488 and anti-rabbit Alexa Fluor® 568. Image generously submitted to the 2017 Cell Life Imaging Competition by Kathleen Ignatoski from University of Michigan.
  • 3_KifLiakath.jpg
    Whole mount mouse tail epidermis was stained with purified anti-Keratin 14 (green, clone Poly19053), purified anti-Keratin 15 (orange, clone Poly18339) and DAPI (blue). Image generously submitted to the 2017 Cell Life Imaging Competition by Kif Liakath.
  • 4_DAPI_IF_080712
    Human cervical cancer cell line, HeLa, was fixed with 4% paraformaldehyde and stained with 300 nM DAPI.
  • 5_DAPI_080712
    Human cervical cancer cell line, HeLa, was fixed with 4% paraformaldehyde and stained with 300 nM DAPI.
See DAPI (4',6-Diamidino-2-Phenylindole, Dilactate) spectral data
Cat # Size Price Quantity Check Availability Save
422801 10 mg SEK849
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

DAPI (4',6-Diamidino-2-Phenylindole, Dilactate), a blue fluorescent nucleic acid stain, preferentially binds dsDNA and associates with the minor groove AT clusters. The molecular weight for DAPI is 457.5.  Association of DAPI with dsDNA increases fluorescence approximately 20-fold, with an emission maximum of 460 nm. The increase in fluorescence is believed to be due to displacement of water molecules from the minor groove and DAPI. DAPI can also bind RNA and emits at a longer wavelength of 500 nm, with only a 20% increase in fluorescence.

DAPI is a popular nuclear stain for identification of cell cycle and specifically stains nuclei but not cytoplasm. The dilactate form is more water soluble compared to the dihydrochloride form.

DAPI can be excited by a UV laser, xenon, or a mercury-arc lamp. 

Product Details
Technical Data Sheet (pdf)

Product Details

Formulation
Lyophilized
Preparation
To make 5 mg/ml (10.9 mM) solution, dissolve entire contents of vial in 2 ml of deionized water.
Storage & Handling
Store between 2°C and 8°C, protected from light. For long term storage, aliquot and store at -20°C.
Application

ICFC, ICC
Recommended Usage

This product can be used at 30 µM for flow cytometry and 300 nM for immunofluorescence.  It is recommended to titrate the dye for optimal performance. 

Excitation Laser
Ultraviolet Laser (355 nm)
Application Notes

Protocols for Counterstaining with DAPI:

Immunofluorescence Staining
Note: Cells may be fixed by method of choice, such as with 4% paraformaldehyde. DAPI staining is done after staining for other markers. Fixation and permeabilization of cells is not necessary to counterstain with DAPI.

1. Fix cells using method of choice.
2. Incubate the cells with phosphate buffered saline (PBS) for 15 minutes.
3. Dilute the DAPI solution (we recommend to 300 nM) with PBS. Remove excess PBS from the slide and cover with DAPI solution, making sure the cells are completely covered.
4. Incubate for up to 5 minutes. Rinse the slide several times to remove all free DAPI. It is recommended to use a mounting medium with antifade reagent to reduce fluorescence quenching. The slide is ready to view under the microscope with appropriate filters.


Nuclear Staining for Flow Cytometry
Note: Cells may be fixed with 4% paraformadehyde or absolute ethanol.

1. Fix cells with absolute ethanol or 4% paraformaldehyde.
2. Centrifuge, discard the supernatant, and add 5 ml of PBS, allowing cells to rehydrate for 15 minutes.
3. Dilute the DAPI to 30 µM (recommended) in staining buffer (such as BioLegend's FOXP3 Perm Buffer, Cat. No. 421402).
4. Centrifuge cell suspension from step 3 above, discard supernatant, and add 1 ml of DAPI solution; then incubate at room temperature for 15 minutes.
5. Analyze by flow cytometry using an instrument with appropriate lasers.

Additional Product Notes

View more applications data for this product in our Scientific Poster Library.

Application References
  1. Solomonov I, et al. 2014. Sci Rep. 4:5987. PubMed
  2. Sodhi CP, et al. 2015. J Immunol. 194:4931. PubMed
Product Citations
  1. Sierro F, et al. 2017. Immunity. 47:374. PubMed
  2. Wiedemann SJ, et al. 2022. Cell Metab. 34:991. PubMed
  3. Michalek S, et al. 2022. EMBO Rep. 23:e54195. PubMed
  4. Cherkaoui S, et al. 2022. Mol Syst Biol. 18:e11033. PubMed
  5. Chang L, et al. 2023. Life Sci Alliance. 6:. PubMed
  6. Kozlovski S, et al. 2023. Front Immunol. 13:1041552. PubMed
  7. Vanneste D, et al. 2023. Nat Immunol. 24:827. PubMed
  8. Flinn MA, et al. 2023. Front Cardiovasc Med. 10:1142612. PubMed
  9. Ramalingam P, et al. 2023. Nat Commun. 14:2018. PubMed
  10. Huber M, et al. 2023. Nat Commun. 14:2143. PubMed
  11. Kerkering J, et al. 2023. J Clin Invest. . PubMed
  12. Basta MD, et al. 2023. iScience. 26:106570. PubMed
  13. Arora S, et al. 2023. PLoS One. 18:e0286211. PubMed
  14. Gómez-Pinedo U, et al. 2023. Cells. 12:. PubMed
  15. Hoover MY, et al. 2023. Nat Protoc. . PubMed
  16. Davila ML, et al. 2022. iScience. 25:104426. PubMed
  17. DeDreu J, et al. 2021. Matrix Biol. 96:18. PubMed
  18. Duraiswamy J, et al. 2021. Cancer Cell. 39:1623. PubMed
  19. McCubbrey AL, et al. 2022. Cell Rep. 38:110222. PubMed
  20. Xiang J, et al. 2022. J Virol. 96:e0005722. PubMed
  21. Matta B, et al. 2022. Front Immunol. 13:951254. PubMed
  22. Kimmerling RJ, et al. 2022. Commun Biol. 5:1295. PubMed
  23. Reemst K, et al. 2022. Transl Psychiatry. 12:507. PubMed
  24. Kaneko K, et al. 2022. Cancers (Basel). 14: . PubMed
  25. Shahid AM, et al. 2022. PLoS One. 17:e0278209. PubMed
  26. Sountoulidis A, et al. 2023. Nat Cell Biol. 25:351. PubMed
  27. Wang CQ, et al. 2023. Cells. 12: . PubMed
  28. Jeon EY, et al. 2023. Bioeng Transl Med. 8:e10362. PubMed
  29. Xiong E, et al. 2023. Front Immunol. 13:1083119. PubMed
  30. Aru B, et al. 2023. Balkan Med J. 40:117. PubMed
  31. González-Terán B, et al. 2022. Cell. 185:794. PubMed
  32. Grubwieser P, et al. 2022. Front Cell Infect Microbiol. 12:875543. PubMed
  33. Wu N, et al. 2020. Cell Rep. 30:1129. PubMed
  34. Velilla J, et al. 2019. Neurol Genet. 5:e312. PubMed
  35. Jiao Q, et al. 2017. Clin Exp Immunol. 188:420. PubMed
  36. Rodrigues M, et al. 2022. Biochem J. 479:1891. PubMed
  37. Gabriely G, et al. 2021. iScience. 24:103347. PubMed
  38. Effern M, et al. 2022. STAR Protoc. 3:101038. PubMed
  39. Sountoulidis A, et al. 2020. PLoS Biol. 18:e3000675. PubMed
  40. Mester B, et al. 2015. PLoS One. 10: e0140432. PubMed
  41. Kobayashi T, et al. 2019. Cell. 176:982. PubMed
  42. Anguiano T, et al. 2020. Toxicol Sci. 177:494. PubMed
  43. Afshar Y, et al. 2021. Nat Commun. 12:4408. PubMed
  44. Goodnough LH, et al. 2022. Front Endocrinol (Lausanne). 13:924927. PubMed
  45. Nguyen DT, et al. 2022. Cells. 11:. PubMed
  46. Baldominos P, et al. 2022. STAR Protoc. 3:101795. PubMed
  47. Wilson K, et al. 2016. Cell Death Dis. 7: e2197. PubMed
  48. Miedema A, et al. 2022. Acta Neuropathol Commun. 10:8. PubMed
  49. Emmons TR, et al. 2021. Cancer Immunol Res. 9:790. PubMed
  50. Valkov N, et al. 2021. Life Sci Alliance. 4:. PubMed
  51. Gamboa CM, et al. 2021. STAR Protoc. 100345:2. PubMed
  52. Sugawara E, et al. 2020. Autophagy. 1.323611111. PubMed
  53. Elias A, et al. 2016. Sci Rep. 6: 24971. PubMed
  54. Brunner JS, et al. 2020. Nat Commun. 0.757638889. PubMed
  55. Fukushima T, et al. 2019. Cell Rep. 29:4144. PubMed
  56. Bannard O, et al. 2016. J Exp Med. 13: 993 - 1009. PubMed
  57. Sumitomo Y, et al. 2016. Blood. 128: 1614 - 1624. PubMed
  58. Paris AJ, et al. 2020. Nat Cell Biol. 1.747916667. PubMed
  59. Zhang M, et al. 2017. Oncol Lett. 3.069444444. PubMed
  60. Greenblatt SM, et al. 2018. Cancer Cell. 33:1111. PubMed
  61. Alexander MS, et al. 2021. Muscle Nerve. 63:928. PubMed
  62. Hendricks A, et al. 2021. Front Oncol. 11:646885. PubMed
  63. Hiramatsu-Asano S, et al. 2021. Front Immunol. 11:616141. PubMed
  64. Ambrosi TH, et al. 2021. Elife. 10: . PubMed
  65. Hopp AK, et al. 2021. Mol Cell. 81:340. PubMed
  66. Allam O, et al. 2018. PLoS One. 13:e0194185. PubMed
  67. Wilson AS, et al. 2022. Nat Commun. 13:528. PubMed
  68. Deng J, et al. 2021. Breast Cancer Res Treat. 185:85. PubMed
  69. DeDreu J, et al. 2020. FASEB J. 34:9316. PubMed
  70. Kanda K, et al. 2018. JCI Insight. 3:e91316. PubMed
  71. Fujiwara H, et al. 2021. Nat Immunol. 22:1440. PubMed
  72. Ravi A, et al. 2021. Dev Cell. 56:1661. PubMed
  73. Wu CL, et al. 2021. Nat Commun. 12:362. PubMed
  74. Koh P, et al. 2016. Sci Data. 3:160109. PubMed
  75. Sodhi C, et al. 2015. J Immunol. 194:4931. PubMed
  76. Wang ECE, et al. 2019. Cell Stem Cell. 24:654. PubMed
  77. So EY, et al. 2021. Am J Physiol Cell Physiol. 321:C569. PubMed
  78. Poulos M, et al. 2016. Nat Commun. 7:13829. PubMed
  79. Noah AC, et al. 2020. J Appl Physiol (1985). 473:128. PubMed
  80. Teo YV, et al. 2019. Cell Rep. 27:997. PubMed
  81. Hayama Y, et al. 2018. J Immunol. 200:3790. PubMed
  82. Fredriksson-Lidman K, et al. 2017. PLoS One. 10.1371/journal.pone.0185509. PubMed
  83. Wennerberg E, et al. 2022. Sci Transl Med. 14:eabe8195. PubMed
  84. Kumar A, et al. 2021. STAR Protoc. 2:100874. PubMed
  85. Hendricks A, et al. 2020. Cancers (Basel). 12:00. PubMed
  86. Aronovich A, et al. 2021. J Invest Dermatol. 141:619. PubMed
  87. Caeser R, et al. 2021. Nat Protoc. 16:2499. PubMed
  88. Faisal S, et al. 2016. Sci Rep. 6:39530. PubMed
  89. Kundu K, et al. 2019. Cancer Immunol Res. 1.069444444. PubMed
  90. Pagan JD, et al. 2018. Cell. 172:564. PubMed
  91. Zhang X, et al. 2022. JCI Insight. 7:. PubMed
  92. Zhu M, et al. 2021. Eneuro. 8:. PubMed
  93. Flores-Pliego A, et al. 2021. Cells. 10:. PubMed
  94. Shani O, et al. 2021. Elife. 10: . PubMed
  95. Thompson M, et al. 2015. J Immunol. 195: 5637 - 5647. PubMed
  96. Mould KJ, et al. 2019. JCI Insight. 4:00. PubMed
  97. Heath O, et al. 2021. Cancer Immunol Res. 9:665. PubMed
  98. Dasinger JH, et al. 2021. Pregnancy Hypertens. 24:126. PubMed
  99. Ren X, et al. 2022. STAR Protoc. 3:101818. PubMed
  100. Moser J, et al. 2016. Sci Rep. 6:35387. PubMed
  101. Yanting C, et al. 2018. J Dairy Sci. 101:1601. PubMed
  102. Kurena B, et al. 2017. Front Immunol. 1.490972222. PubMed
  103. Pinho–Ribeiro FA, et al. 2018. Cell. 173:1083. PubMed
  104. Aziz M, et al. 2017. J Immunol. 10.4049/jimmunol.1602056. PubMed
  105. Pascual-Pasto G, et al. 2022. J Immunother Cancer. 10:. PubMed
  106. Lehrke MJ, et al. 2021. Elife. 10:. PubMed
  107. Wang Y, et al. 2021. EMBO Mol Med. 13:e14089. PubMed
  108. Correa A, et al. 2015. PLoS One. 10: 0143391. PubMed
  109. Chiang M, et al. 2019. Cell Rep. 28:3212. PubMed
  110. Valdespino-Vázquez MY, et al. 2021. J Med Virol. 93:4480. PubMed
  111. Kissiov DU, et al. 2022. Elife. 11:. PubMed
  112. Isobe T, et al. 2022. Nat Commun. 13:4501. PubMed
  113. Dent JR, et al. 2019. J Appl Physiol (1985). 127:1117. PubMed
  114. Schmidt A, et al. 2017. Toxicol Lett. 10.1016/j.toxlet.2017.08.008. PubMed
  115. Canals Hernaez D, et al. 2022. Front Oncol. 12:856424. PubMed
  116. Mascharak S, et al. 2022. Cell Stem Cell. 29:315. PubMed
  117. Rodriguez A, et al. 2021. Cell Stem Cell. 28:33. PubMed
  118. Pang J, et al. 2021. STAR Protoc. 2:100879. PubMed
  119. Haschak M, et al. 2021. Aging (Albany NY). 13:16938. PubMed
  120. Phan TS, et al. 2021. Sci Adv. 7:. PubMed
  121. Stancil IT, et al. 2021. Nat Commun. 12:4566. PubMed
  122. Margaroli C, et al. 2021. Cell Rep Med. :100242. PubMed
  123. Caporarello N, et al. 2020. Aging Cell. 19:e13196. PubMed
  124. Vergoni B, et al. 2016. Diabetes. 65: 3062 - 3074. PubMed
  125. Burns F, et al. 2015. Aquatic Toxicology. 164: 52-60. PubMed
  126. Stevens M, et al. 2016. Nat Biotechnol. 34:1161-1167. PubMed
  127. Shilts J, et al. 2021. Sci Rep. 0.745138889. PubMed
  128. Jain A, et al. 2020. Nat Immunol. 0.920138889. PubMed
  129. Zheng C, et al. 2022. Acta Pharm Sin B. 12:3726. PubMed
  130. Anisul M, et al. 2021. Elife. 10:. PubMed
  131. DeDreu J, et al. 2022. FASEB J. 36:e21995. PubMed
  132. Pelham-Webb B, et al. 2021. Mol Cell. 81:1732. PubMed
  133. Kohn M, et al. 2021. Front Immunol. 626627:12. PubMed
  134. Chmielewski M and Abken H 2017. Cell Rep.. 10.1016/j.celrep.2017.11.063. PubMed
  135. Hassanein W, et al. 2017. Organogenesis. 13:16. PubMed
  136. Aimi F, et al. 2021. Mod Pathol. 34:1468. PubMed
  137. Barcia Durán JG, et al. 2021. Commun Biol. 4:406. PubMed
  138. Karimzadeh A, et al. 2021. Front Cell Dev Biol. 9:734176. PubMed
  139. Reeves KM, et al. 2021. Clin Cancer Res. Online ahead of print. PubMed
  140. Srijiwangsa P, et al. 2018. BMC Pharmacol Toxicol. 19:32. PubMed
  141. Ladd MR, et al. 2018. Tissue Eng Part C Methods. 24:331. PubMed
  142. Bennett AH, et al. 2018. PLoS Genet. 14:e1007226. PubMed
  143. Doorley L, et al. 2017. Immunobiology.. 10.1016/j.imbio.2017.08.002. PubMed
  144. Guo P, et al. 2022. Nat Cell Biol. 24:99. PubMed
  145. Tominaga K, et al. 2022. iScience. 25:103667. PubMed
  146. Chen HY, et al. 2020. J Immunol. 1158:204. PubMed
  147. Gosztyla C, et al. 2020. Tissue Eng Part C Methods. 26:67. PubMed
  148. Köhler VK, et al. 2020. Int J Mol Sci. 21:00. PubMed
  149. Solomonov I, et al. 2014. Sci Rep. 4:5987. PubMed
  150. Sierro F, et al. 2017. Immunity. 47:374. PubMed
  151. Wiedemann SJ, et al. 2022. Cell Metab. 34:991. PubMed
  152. Michalek S, et al. 2022. EMBO Rep. 23:e54195. PubMed
  153. Cherkaoui S, et al. 2022. Mol Syst Biol. 18:e11033. PubMed
  154. Chang L, et al. 2023. Life Sci Alliance. 6:. PubMed
  155. Kozlovski S, et al. 2023. Front Immunol. 13:1041552. PubMed
  156. Vanneste D, et al. 2023. Nat Immunol. 24:827. PubMed
  157. Flinn MA, et al. 2023. Front Cardiovasc Med. 10:1142612. PubMed
  158. Ramalingam P, et al. 2023. Nat Commun. 14:2018. PubMed
  159. Huber M, et al. 2023. Nat Commun. 14:2143. PubMed
  160. Kerkering J, et al. 2023. J Clin Invest. . PubMed
  161. Basta MD, et al. 2023. iScience. 26:106570. PubMed
  162. Arora S, et al. 2023. PLoS One. 18:e0286211. PubMed
  163. Gómez-Pinedo U, et al. 2023. Cells. 12:. PubMed
  164. Hoover MY, et al. 2023. Nat Protoc. . PubMed
  165. Davila ML, et al. 2022. iScience. 25:104426. PubMed
  166. DeDreu J, et al. 2021. Matrix Biol. 96:18. PubMed
  167. Duraiswamy J, et al. 2021. Cancer Cell. 39:1623. PubMed
  168. McCubbrey AL, et al. 2022. Cell Rep. 38:110222. PubMed
  169. Xiang J, et al. 2022. J Virol. 96:e0005722. PubMed
  170. Matta B, et al. 2022. Front Immunol. 13:951254. PubMed
  171. Kimmerling RJ, et al. 2022. Commun Biol. 5:1295. PubMed
  172. Reemst K, et al. 2022. Transl Psychiatry. 12:507. PubMed
  173. Kaneko K, et al. 2022. Cancers (Basel). 14: . PubMed
  174. Shahid AM, et al. 2022. PLoS One. 17:e0278209. PubMed
  175. Sountoulidis A, et al. 2023. Nat Cell Biol. 25:351. PubMed
  176. Wang CQ, et al. 2023. Cells. 12: . PubMed
  177. Jeon EY, et al. 2023. Bioeng Transl Med. 8:e10362. PubMed
  178. Xiong E, et al. 2023. Front Immunol. 13:1083119. PubMed
  179. Aru B, et al. 2023. Balkan Med J. 40:117. PubMed
  180. González-Terán B, et al. 2022. Cell. 185:794. PubMed
  181. Grubwieser P, et al. 2022. Front Cell Infect Microbiol. 12:875543. PubMed
  182. Wu N, et al. 2020. Cell Rep. 30:1129. PubMed
  183. Velilla J, et al. 2019. Neurol Genet. 5:e312. PubMed
  184. Jiao Q, et al. 2017. Clin Exp Immunol. 188:420. PubMed
  185. Rodrigues M, et al. 2022. Biochem J. 479:1891. PubMed
  186. Gabriely G, et al. 2021. iScience. 24:103347. PubMed
  187. Effern M, et al. 2022. STAR Protoc. 3:101038. PubMed
  188. Sountoulidis A, et al. 2020. PLoS Biol. 18:e3000675. PubMed
  189. Mester B, et al. 2015. PLoS One. 10: e0140432. PubMed
  190. Kobayashi T, et al. 2019. Cell. 176:982. PubMed
  191. Anguiano T, et al. 2020. Toxicol Sci. 177:494. PubMed
  192. Afshar Y, et al. 2021. Nat Commun. 12:4408. PubMed
  193. Goodnough LH, et al. 2022. Front Endocrinol (Lausanne). 13:924927. PubMed
  194. Nguyen DT, et al. 2022. Cells. 11:. PubMed
  195. Baldominos P, et al. 2022. STAR Protoc. 3:101795. PubMed
  196. Wilson K, et al. 2016. Cell Death Dis. 7: e2197. PubMed
  197. Miedema A, et al. 2022. Acta Neuropathol Commun. 10:8. PubMed
  198. Emmons TR, et al. 2021. Cancer Immunol Res. 9:790. PubMed
  199. Valkov N, et al. 2021. Life Sci Alliance. 4:. PubMed
  200. Gamboa CM, et al. 2021. STAR Protoc. 100345:2. PubMed
  201. Sugawara E, et al. 2020. Autophagy. 1.323611111. PubMed
  202. Elias A, et al. 2016. Sci Rep. 6: 24971. PubMed
  203. Brunner JS, et al. 2020. Nat Commun. 0.757638889. PubMed
  204. Fukushima T, et al. 2019. Cell Rep. 29:4144. PubMed
  205. Bannard O, et al. 2016. J Exp Med. 13: 993 - 1009. PubMed
  206. Sumitomo Y, et al. 2016. Blood. 128: 1614 - 1624. PubMed
  207. Paris AJ, et al. 2020. Nat Cell Biol. 1.747916667. PubMed
  208. Zhang M, et al. 2017. Oncol Lett. 3.069444444. PubMed
  209. Greenblatt SM, et al. 2018. Cancer Cell. 33:1111. PubMed
  210. Alexander MS, et al. 2021. Muscle Nerve. 63:928. PubMed
  211. Hendricks A, et al. 2021. Front Oncol. 11:646885. PubMed
  212. Hiramatsu-Asano S, et al. 2021. Front Immunol. 11:616141. PubMed
  213. Ambrosi TH, et al. 2021. Elife. 10: . PubMed
  214. Hopp AK, et al. 2021. Mol Cell. 81:340. PubMed
  215. Allam O, et al. 2018. PLoS One. 13:e0194185. PubMed
  216. Wilson AS, et al. 2022. Nat Commun. 13:528. PubMed
  217. Deng J, et al. 2021. Breast Cancer Res Treat. 185:85. PubMed
  218. DeDreu J, et al. 2020. FASEB J. 34:9316. PubMed
  219. Kanda K, et al. 2018. JCI Insight. 3:e91316. PubMed
  220. Fujiwara H, et al. 2021. Nat Immunol. 22:1440. PubMed
  221. Ravi A, et al. 2021. Dev Cell. 56:1661. PubMed
  222. Wu CL, et al. 2021. Nat Commun. 12:362. PubMed
  223. Koh P, et al. 2016. Sci Data. 3:160109. PubMed
  224. Sodhi C, et al. 2015. J Immunol. 194:4931. PubMed
  225. Wang ECE, et al. 2019. Cell Stem Cell. 24:654. PubMed
  226. So EY, et al. 2021. Am J Physiol Cell Physiol. 321:C569. PubMed
  227. Poulos M, et al. 2016. Nat Commun. 7:13829. PubMed
  228. Noah AC, et al. 2020. J Appl Physiol (1985). 473:128. PubMed
  229. Teo YV, et al. 2019. Cell Rep. 27:997. PubMed
  230. Hayama Y, et al. 2018. J Immunol. 200:3790. PubMed
  231. Fredriksson-Lidman K, et al. 2017. PLoS One. 10.1371/journal.pone.0185509. PubMed
  232. Wennerberg E, et al. 2022. Sci Transl Med. 14:eabe8195. PubMed
  233. Kumar A, et al. 2021. STAR Protoc. 2:100874. PubMed
  234. Hendricks A, et al. 2020. Cancers (Basel). 12:00. PubMed
  235. Aronovich A, et al. 2021. J Invest Dermatol. 141:619. PubMed
  236. Caeser R, et al. 2021. Nat Protoc. 16:2499. PubMed
  237. Faisal S, et al. 2016. Sci Rep. 6:39530. PubMed
  238. Kundu K, et al. 2019. Cancer Immunol Res. 1.069444444. PubMed
  239. Pagan JD, et al. 2018. Cell. 172:564. PubMed
  240. Zhang X, et al. 2022. JCI Insight. 7:. PubMed
  241. Zhu M, et al. 2021. Eneuro. 8:. PubMed
  242. Flores-Pliego A, et al. 2021. Cells. 10:. PubMed
  243. Shani O, et al. 2021. Elife. 10: . PubMed
  244. Thompson M, et al. 2015. J Immunol. 195: 5637 - 5647. PubMed
  245. Mould KJ, et al. 2019. JCI Insight. 4:00. PubMed
  246. Heath O, et al. 2021. Cancer Immunol Res. 9:665. PubMed
  247. Dasinger JH, et al. 2021. Pregnancy Hypertens. 24:126. PubMed
  248. Ren X, et al. 2022. STAR Protoc. 3:101818. PubMed
  249. Moser J, et al. 2016. Sci Rep. 6:35387. PubMed
  250. Yanting C, et al. 2018. J Dairy Sci. 101:1601. PubMed
  251. Kurena B, et al. 2017. Front Immunol. 1.490972222. PubMed
  252. Pinho–Ribeiro FA, et al. 2018. Cell. 173:1083. PubMed
  253. Aziz M, et al. 2017. J Immunol. 10.4049/jimmunol.1602056. PubMed
  254. Pascual-Pasto G, et al. 2022. J Immunother Cancer. 10:. PubMed
  255. Lehrke MJ, et al. 2021. Elife. 10:. PubMed
  256. Wang Y, et al. 2021. EMBO Mol Med. 13:e14089. PubMed
  257. Correa A, et al. 2015. PLoS One. 10: 0143391. PubMed
  258. Chiang M, et al. 2019. Cell Rep. 28:3212. PubMed
  259. Valdespino-Vázquez MY, et al. 2021. J Med Virol. 93:4480. PubMed
  260. Kissiov DU, et al. 2022. Elife. 11:. PubMed
  261. Isobe T, et al. 2022. Nat Commun. 13:4501. PubMed
  262. Dent JR, et al. 2019. J Appl Physiol (1985). 127:1117. PubMed
  263. Schmidt A, et al. 2017. Toxicol Lett. 10.1016/j.toxlet.2017.08.008. PubMed
  264. Canals Hernaez D, et al. 2022. Front Oncol. 12:856424. PubMed
  265. Mascharak S, et al. 2022. Cell Stem Cell. 29:315. PubMed
  266. Rodriguez A, et al. 2021. Cell Stem Cell. 28:33. PubMed
  267. Pang J, et al. 2021. STAR Protoc. 2:100879. PubMed
  268. Haschak M, et al. 2021. Aging (Albany NY). 13:16938. PubMed
  269. Phan TS, et al. 2021. Sci Adv. 7:. PubMed
  270. Stancil IT, et al. 2021. Nat Commun. 12:4566. PubMed
  271. Margaroli C, et al. 2021. Cell Rep Med. :100242. PubMed
  272. Caporarello N, et al. 2020. Aging Cell. 19:e13196. PubMed
  273. Vergoni B, et al. 2016. Diabetes. 65: 3062 - 3074. PubMed
  274. Burns F, et al. 2015. Aquatic Toxicology. 164: 52-60. PubMed
  275. Stevens M, et al. 2016. Nat Biotechnol. 34:1161-1167. PubMed
  276. Shilts J, et al. 2021. Sci Rep. 0.745138889. PubMed
  277. Jain A, et al. 2020. Nat Immunol. 0.920138889. PubMed
  278. Zheng C, et al. 2022. Acta Pharm Sin B. 12:3726. PubMed
  279. Anisul M, et al. 2021. Elife. 10:. PubMed
  280. DeDreu J, et al. 2022. FASEB J. 36:e21995. PubMed
  281. Pelham-Webb B, et al. 2021. Mol Cell. 81:1732. PubMed
  282. Kohn M, et al. 2021. Front Immunol. 626627:12. PubMed
  283. Chmielewski M and Abken H 2017. Cell Rep.. 10.1016/j.celrep.2017.11.063. PubMed
  284. Hassanein W, et al. 2017. Organogenesis. 13:16. PubMed
  285. Aimi F, et al. 2021. Mod Pathol. 34:1468. PubMed
  286. Barcia Durán JG, et al. 2021. Commun Biol. 4:406. PubMed
  287. Karimzadeh A, et al. 2021. Front Cell Dev Biol. 9:734176. PubMed
  288. Reeves KM, et al. 2021. Clin Cancer Res. Online ahead of print. PubMed
  289. Srijiwangsa P, et al. 2018. BMC Pharmacol Toxicol. 19:32. PubMed
  290. Ladd MR, et al. 2018. Tissue Eng Part C Methods. 24:331. PubMed
  291. Bennett AH, et al. 2018. PLoS Genet. 14:e1007226. PubMed
  292. Doorley L, et al. 2017. Immunobiology.. 10.1016/j.imbio.2017.08.002. PubMed
  293. Guo P, et al. 2022. Nat Cell Biol. 24:99. PubMed
  294. Tominaga K, et al. 2022. iScience. 25:103667. PubMed
  295. Chen HY, et al. 2020. J Immunol. 1158:204. PubMed
  296. Gosztyla C, et al. 2020. Tissue Eng Part C Methods. 26:67. PubMed
  297. Köhler VK, et al. 2020. Int J Mol Sci. 21:00. PubMed
  298. Solomonov I, et al. 2014. Sci Rep. 4:5987. PubMed

Antigen Details

Biology Area
Cell Biology, Cell Cycle/DNA Replication, Neuroscience
Antigen References

1. Langlois RG, et al. 1980. Chromosoma. 77:229.
2. Kubista M, et al. 1987. Biochemistry 26:4545.

Gene ID
NA
Go To Top Version: 2    Revision Date: 04-24-2025

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account